Regard is a healthcare technology company building an AI-powered Clinical Insights Platform that integrates with electronic health record (EHR) systems to analyze patient data, recommend diagnoses, generate care plans, and automate documentation.[1][3][5] It serves physicians, clinicians, and hospital administrators by addressing the "Clinical Insights Gap"—where clinicians review only about 3% of a patient's average 50,000 data points at the point of care—enabling proactive insights, reduced errors, improved patient outcomes, and revenue optimization through better coding and billing.[1][3][5] With strong growth momentum, Regard has raised $106.3M in funding (including a $91M round), employs 75-200 people across offices in New York (HQ), Los Angeles, and other locations, and reports clinician acceptance of recommended diagnoses while delivering results like $7M revenue increases and 30% time savings for clients like Sentara Health.[2][4][5]
Regard was founded in 2017 by a team blending healthcare, engineering, and product expertise, including CEO Eli Ben-Joseph, President/COO Nate Wilson, Head of Product Danny Tryon, and Chief Medical Information Officer Francisco Alvarez, MD.[1][2] The idea emerged from recognizing the disconnect between vast patient data in EHRs and actionable insights for clinicians, leading to a platform designed around physician workflows to synthesize historical data, automate notes, and recommend diagnoses.[1][2][3] Early traction built on this foundation, evolving into a growth-stage firm headquartered in New York with hybrid/remote operations, rapid hiring (e.g., senior engineering roles), and significant venture funding that fueled expansion to 51-200 employees.[1][2][4]
Regard rides the AI-in-healthcare wave, capitalizing on exploding EHR data volumes and clinician burnout from administrative overload amid post-pandemic staffing shortages.[1][5] Timing is ideal as regulations push value-based care and precise documentation for reimbursement, with market forces like HIPAA-compliant AI adoption favoring scalable platforms that enhance diagnostics without disrupting workflows.[3] It influences the ecosystem by setting standards for proactive clinical decision support (CDS), clinical documentation integrity (CDI), and AI summaries, enabling hospitals to prioritize patient safety over paperwork and accelerating industry shifts toward AI co-pilots.[3][5]
Regard is poised for accelerated adoption as AI maturity in healthcare deepens, with expansions into more EHRs, international markets, and advanced features like real-time predictive analytics driving further revenue capture and outcome improvements.[3][5] Trends like multimodal AI and regulatory tailwinds for auditable tools will shape its path, potentially evolving it into a dominant platform influencing hospital operations globally. This positions Regard to not just close the insights gap, but redefine proactive medicine from its strong foundation in clinician-centric innovation.[1][5]
Regard has raised $81.0M in total across 3 funding rounds.
Regard's investors include BlueCross BlueShield Venture Partners, Calibrate Ventures, CVS Health, Evergreen Climate Innovations, Kleiner Perkins, Oak HC/FT, Sandbox Industries, Shield Capital, Techstars, TenOneTen Ventures, Drew Houston, Scot Wingo.
Regard has raised $81.0M across 3 funding rounds. Most recently, it raised $61.0M Series B in June 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2024 | $61.0M Series B | BlueCross BlueShield Venture Partners, Calibrate Ventures, CVS Health, Evergreen Climate Innovations, Kleiner Perkins, Oak HC/FT, Sandbox Industries, Shield Capital, Techstars, TenOneTen Ventures, Drew Houston, Scot Wingo, Sue Bird | |
| Jun 1, 2022 | $15.0M Series A | Calibrate Ventures, Fin Capital, Goat Capital, GSR Ventures, Kleiner Perkins, Mantis VC, Oak HC/FT, Point72 Ventures, Shield Capital, Techstars, TenOneTen Ventures, What If Ventures, Drew Houston, Scot Wingo, Sue Bird | |
| Feb 1, 2021 | $5.0M Seed | Calibrate Ventures, Kleiner Perkins, Oak HC/FT, Shield Capital, Techstars, TenOneTen Ventures, Drew Houston, Scot Wingo, Sue Bird |
